Abivardi Signer Golnar has disclosed significant shareholdings in vVARDIS Holding AG through a recent filing. This report, filed on November 12, 2026, reveals the strategic positioning of Golnar within the surgical and medical instruments sector. The filing is particularly noteworthy as it highlights Golnar's ownership of over 25 million shares in vVARDIS, indicating a strong commitment to the company's future.

vVARDIS Holding AG, a company based in Zug, Switzerland, operates in the surgical and medical instruments and apparatus sector. It is classified under the Standard Industrial Classification (SIC) code 3841. The recent filing by Golnar is part of a series of disclosures, with another filing made just a day later on November 13, 2026.

The filing states that Golnar currently holds 8,502,386 ordinary shares directly and an additional 16,913,905 shares indirectly through vVardis Investment Holding AG. This ownership structure demonstrates Golnar's significant influence over the company. The filing notes that these shares will be reclassified into Class A ordinary shares prior to the completion of vVARDIS's initial public offering.

Golnar is not just a shareholder but also serves as Co-CEO, Co-Founder, and Co-Chair of the company, which further emphasizes her pivotal role in vVARDIS's strategic direction. The filing also indicates that Golnar has controlling voting and dispositive power over the shares held by vVardis Investment Holding AG, although she disclaims beneficial ownership of those securities for purposes of Section 16.

This update may affect various stakeholders, including investors, employees, and competitors within the surgical and medical instruments industry. The substantial holdings reported by Golnar could lead to increased scrutiny and competition among firms in this sector as they navigate the implications of her influential position.

Looking ahead, the filing does not specify what actions may follow this significant disclosure. However, the upcoming initial public offering of vVARDIS Holding AG is anticipated, which could further shape the landscape of the surgical and medical instruments market.